LGND Rule 144: Notice of 467 Common Shares

LGND Rule 144 notice reporting proposed sales of Common shares.

Rhea-AI Filing Summary

LGND Rule 144 notice reporting proposed sales of Common shares. The filing lists 467 shares referenced repeatedly, an issuer listing at Nasdaq, and three recent sale entries by John Kozarich dated 02/02/2026, 03/02/2026, and 04/01/2026 with numeric values shown beside each entry.

Key Figures

Shares referenced: 467 shares Numeric entry: 107349.29 Numeric entry: 19941141 +3 more

6 metrics

Shares referenced 467 shares appears next to security and sale entries

Numeric entry 107349.29 listed in securities information block

Numeric entry 19941141 listed in securities information block

Sale value 91,490.02 adjacent to 02/02/2026 sale by John Kozarich

Sale value 93,632.38 adjacent to 03/02/2026 sale by John Kozarich

Sale value 94,440.10 adjacent to 04/01/2026 sale by John Kozarich

Key Terms

Rule 144, Issuer, Nasdaq, Securities To Be Sold

4 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Issuer financial

"Issuer | | | 467 | 04/24/2024"

Nasdaq market

"05/01/2026 | Nasdaq 144: Securities To Be Sold"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does LGND's Rule 144 filing report?

It reports proposed or recent sales of Common shares under Rule 144 by an affiliate. The notice references 467 shares repeatedly and lists transaction dates and numeric values tied to each sale entry.

Who is the reported seller in the LGND Rule 144 filing?

The filing lists John Kozarich as the reported seller with an address shown. Multiple sale entries are dated 02/02/2026, 03/02/2026, and 04/01/2026 alongside numeric figures.

How many shares are referenced in the LGND filing?

The document repeatedly references the figure 467, which appears next to the security lines and sale entries. The filing does not provide additional aggregated totals or proceeds descriptions.

Does the filing state where the shares are listed?

Yes; the notice includes Nasdaq as the market listing. It also names UBS Financial Services, Inc. in the securities information section, without specifying execution method or proceeds recipient.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 04:16 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001223000
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LIGAND PHARMACEUTICALS INC
SEC File Number	001-33093
Address of Issuer	3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CALIFORNIA 92121
Phone	858-550-7500
Name of Person for Whose Account the Securities are To Be Sold	KOZARICH JOHN W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	467	107349.29	19941141	05/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/24/2024	Various	Issuer			467	04/24/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Kozarich 3911 Sorrentino Valley Blvd. Suite 110 San Diego CA 92121	Common	02/02/2026	467	91490.02
John Kozarich 3911 Sorrentino Valley Boulevard Suite 110 San Diego CA 92121	Common	03/02/2026	467	93632.38
John Kozarich 3911 Sorrentino Valley Blvd Suite 110 San Diego CA 92121	Common	04/01/2026	467	94440.10

144: Remarks and Signature

Remarks
Date of Notice	05/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for John Kozarich
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)